Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.13M 1.96M 1.82M 3.46M 231M 3.51M 23.55M 9.16M 114M 9.14M 8.95M 394M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.9M 10.05M 9.31M 17.68M 1.18B 17.96M 120M 46.85M 584M 46.77M 45.76M 2.02B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+0.94%0.00% - - 23.04B
-4.07%+5.67%-29.06%+18.00% 16.63B
-1.79%+5.74%-48.91%-59.80% 7.87B
+6.01%+6.83%+15.71%+80.12% 7.65B
-2.81%+2.82%-18.42%+257.75% 4.69B
+2.48%-0.76%-38.65%-35.05% 2.21B
+0.89%+2.10%-38.52%-47.85% 1.74B
-0.11%+8.57%+9.69%+46.60% 1.53B
0.00%+0.90%+3.69%+78.73% 1.52B
Average +0.08%+3.43%-18.06%+42.31% 6.69B
Weighted average by Cap. -0.32%+4.37%-22.04%+38.31%

Financials

2018 2019 *
Net sales 3.32M 2.91M 2.68M 2.48M 4.71M 315M 4.79M 32.12M 12.49M 156M 12.47M 12.2M 538M -
Net income -15.94M -13.95M -12.85M -11.91M -22.62M -1.51B -22.98M -154M -59.94M -747M -59.84M -58.54M -2.58B -
Net Debt 10.02M 8.77M 8.08M 7.49M 14.22M 951M 14.45M 96.92M 37.69M 469M 37.63M 36.81M 1.62B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock